Serum Institute gets permission to conduct Oxford's coronavirus vaccine Phase 2, 3 human trials in India

Serum Institute of India (SII) has been granted permission by Drugs Controller of General of India (DCGI) to conduct Phase 2, 3 human trials of Oxford-AstraZeneca coronavirus vaccine in India, a government official has said. The vaccine will be called Covishield in India. Serum Institute is already preparing to produce 20 crore -- 200 million -- doses of Covishield.

from IndiaTV: Google News Feed https://ift.tt/2DcPIu6